Loading, please wait ...


News Analytics

ALK Logo jpg?p=facebook.
ROUND ROCK, Texas, June 3, 2021 /PRNewswire/ -- ALK (ALKB:DC / OMX:ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced today that it has acquired OTIPRIO® (ciprofloxacin otic suspension) from Otonomy, Inc. OTIPRIO is a prescription fluoroquinolone antibacterial approved to treat pediatric patients 6 months of age and older with bilateral otitis ...
Google

Subject Matter

  • Healthcare 74.65%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 25.35%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions